Northwest Biotherapeutics, Inc.
(NASDAQ : NWBO)

( )
NWBO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading NWBO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.73%84.861.8%$762.08m
BIIBBiogen Inc.
1.34%245.061.0%$589.61m
CELGCelgene Corporation
2.10%100.701.2%$480.20m
AMGNAmgen Inc.
1.40%154.281.0%$463.67m
REGNRegeneron Pharmaceuticals, Inc.
2.65%358.503.1%$332.54m
ALXNAlexion Pharmaceuticals, Inc.
1.57%118.592.5%$324.94m
ILMNIllumina, Inc.
0.25%140.734.9%$170.93m
TSROTESARO, Inc.
-3.56%81.0615.8%$155.63m
BMRNBioMarin Pharmaceutical Inc.
4.60%81.384.0%$136.26m
VRTXVertex Pharmaceuticals Incorporated
2.00%87.742.6%$136.04m
MDVNMedivation, Inc.
-0.30%60.122.8%$132.41m
SRPTSarepta Therapeutics, Inc.
6.19%20.2549.4%$109.67m
EXASExact Sciences Corporation
0.49%12.3121.4%$104.76m
AAgilent Technologies, Inc.
0.56%44.611.0%$104.68m
ACADACADIA Pharmaceuticals Inc.
5.51%34.2519.6%$101.29m

Company Profile

Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. It engages in the provision of developing cancer vaccines designed to treat a solid tumor cancers. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.